Range
17.2 - 18.56
Vol / Avg.
46.8K/258.8K
Div / Yield
-
52 Wk
14.08 - 23.9
Mkt Cap
462.4M
Payout Ratio
-
Open
18.56
P/E
-
Shares
26.5M
Outstanding
26.5M
Total Float
13.2M
Benzinga - Apr 23, 2021, 10:31AM
Benzinga - Apr 23, 2021, 10:21AM
Benzinga - Apr 23, 2021, 10:16AM
Sector: Health Care.Industry: Pharmaceuticals
Rain Therapeutics Inc is a clinical-stage precision oncology company developing therapies that target oncogenic drivers for which they are able to genetically select patients they believe will most likely benefit. Its lead product candidate, RAIN-32 is a small molecule, oral inhibitor of mouse double minute 2, which is oncogenic in numerous cancers.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-20
REV
Q1 2021Est.ActualSurprise
EPS-1.930
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
RAINRain Therapeutics-5.42%462.4M

Rain Therapeutics Frequently Asked Questions

Q

How do I buy Rain Therapeutics (RAIN) stock?

A

You can purchase shares of Rain Therapeutics (NASDAQ: RAIN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Rain Therapeutics's (RAIN) competitors?

Q

What is the target price for Rain Therapeutics (RAIN) stock?

A

The latest price target for Rain Therapeutics (NASDAQ: RAIN) was reported by Guggenheim on May 18, 2021. The analyst firm set a price target for 26.00 expecting RAIN to rise to within 12 months (a possible 48.91% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Rain Therapeutics (RAIN)?

A

The stock price for Rain Therapeutics (NASDAQ: RAIN) is $17.46 last updated Fri Jul 23 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Rain Therapeutics (RAIN) pay a dividend?

A

There are no upcoming dividends for Rain Therapeutics.

Q

When is Rain Therapeutics (NASDAQ:RAIN) reporting earnings?

A
Rain Therapeutics’s Q2 earnings are confirmed for after-market on August 20, 2021.
Q

Is Rain Therapeutics (RAIN) going to split?

A

There is no upcoming split for Rain Therapeutics.

Q

What sector and industry does Rain Therapeutics (RAIN) operate in?

A

Rain Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.